Catalog

Lupus Anticoagulant a.k.a. Anti-Phospholipid Antibodies: A Further Complication Of COVID-19 Webinar
Online
Added:

FREE FOR MEMBERS!
Description: Lupus Anticoagulant describes an autoimmune disorder in which autoantibodies bind to phospholipids associated with cell membranes which then give rise to Antiphospholipid Antibody Syndrome. Lupus Anticoagulant is truly a misnomer in the sense that very few patients with Systemic Lupus Erythematosus develop these autoantibodies which actually induce thrombosis in vivo. Lupus Anticoagulant has also recently been identified as a complication in the treatment of COVID-19 infection.
This session will provide a history of the discovery of Antiphospholipid Antibody Syndrome, give clarity as to the mechanisms and terminologies of this disorder, and outline the current laboratory methods used for diagnosis.
Start Date: Upon registration
Completion: Up to 52 weeks
Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Type
Name
Sub type
Value
Certificate awarded

Recently Added Items

    There's nothing to show just yet.

About this item

FREE FOR MEMBERS!

Description: Lupus Anticoagulant describes an autoimmune disorder in which autoantibodies bind to phospholipids associated with cell membranes which then give rise to Antiphospholipid Antibody Syndrome.  Lupus Anticoagulant is truly a misnomer in the sense that very few patients with Systemic Lupus Erythematosus develop these autoantibodies which actually induce thrombosis in vivo.  Lupus Anticoagulant has also recently been identified as a complication in the treatment of COVID-19 infection.

This session will provide a history of the discovery of Antiphospholipid Antibody Syndrome, give clarity as to the mechanisms and terminologies of this disorder, and outline the current laboratory methods used for diagnosis.

Start Date: Upon registration

Completion: Up to 52 weeks

Course/Activity Information

At the end of this webinar you will be able to:

  • Provide historical background information for the discovery of Lupus Anticoagulant
  • Describe the laboratory assays used for Lupus Anticoagulant detection and confirmation
  • List the most current data regarding Lupus Anticoagulant development in COVID-19 patients

 

Speaker: Terence Litavec, BSc, MLT, SH(ASCP)

Terence Litavec has worked as a Medical Laboratory Technologist since 2004 and he has served as the MLT Director of the BCSLS.  He currently works in the Hematology Department at LifeLabs in Burnaby, BC.  Before that, he worked at Burnaby Hospital and Kelowna General Hospital, as well as Tacoma General Hospital and PhenoPath Laboratories, both in Washington State.  He is certified by both the CSMLS and the ASCP and he is a certified specialist in hematology and coagulation.  He has always had a passion for teaching, and he has written and presented numerous educational lectures throughout Canada.

 

Recorded: April 21, 2022

 

PEP hours: 1.0

CPS credits: 0

*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.

Close
Shopping Cart
Total:  Close

Loading Shopping Cart Items...